Therapeutic Asset Ratings
373 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Calcium folinate pentahydrate
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P3
BB
(67)
CIS-DIAMMINEDICHLOROPLATINUM II
Pancreatic Cancer
Taiho Oncology, Inc.
P3
BB
(67)
Eloxatin
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P3
BB
(67)
FLUOROURACILUM
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P3
BB
(67)
Capecitabine
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(66)
Irinotecan
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P3
BB
(66)
Nivolumab
Pancreatic Cancer
Orion Corporation, Orion Pharma
P2
B
(63)
S-1
Pancreatic Cancer
Ruijin Hospital
P4
B
(62)
Tislelizumab
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P2
B
(62)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
B
(61)
(+)-VINCRISTINE
Pancreatic Cancer
Fudan University
P2
B
(61)
Cyclophosphamide
Pancreatic Cancer
National Cancer Institute (NCI)
P4
B
(60)
DEXAMETHASONE
Pancreatic Cancer
Takeda
P4
B
(60)
Epirubicin
Pancreatic Cancer
Cambridge University Hospitals NHS Foundation Trust
P4
B
(60)
Pembrolizumab
Pancreatic Cancer
Cambridge University Hospitals NHS Foundation Trust
P4
B
(60)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Pancreatic Cancer
Masonic Cancer Center, University of Minnesota
P3
B
(60)
Cetuximab
Pancreatic Cancer
Revolution Medicines, Inc.
P3
B
(60)
FILGRASTIM
Pancreatic Cancer
General Oncology, Inc.
P3
B
(60)
Docetaxel
Pancreatic Cancer
Hummingbird Bioscience
P2
B
(60)
GVAX
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(60)
LENVATINIB
Pancreatic Cancer
Medical College of Wisconsin
P2
B
(60)
PANITUMUMAB
Pancreatic Cancer
Cancer Trials Ireland
P2
B
(60)
Gvax Pancreas Vaccine
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(59)
TRASTUZUMAB
Pancreatic Cancer
Cancer Research UK
P2/3
B
(59)
Fragmin
Pancreatic Cancer
Helsinki University Central Hospital
P4
B
(58)
Showing 1 to 25 of 373 assets
Previous
Page 1 of 15
Next
